Operating Segments (Details) - Schedule of operating segments - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Revenues
Revenues	$ 2,359,447	$ 4,629,916
Income (Loss) from Operations
Income (Loss) from Operations	(18,586,507)	(10,541,021)
Amortization and Depreciation Expense
Amortization and Depreciation Expense	62,372	54,450
Other Income (Expense), Net
Other Income, Net	61,092	574,753
Share-Based Compensation
Share-Based Compensation	409,933	376,339
Identifiable Assets
Identifiable Assets	19,891,235	7,775,360
Public Health Solutions [Member]
Revenues
Revenues	2,242,078	3,402,014
Income (Loss) from Operations
Income (Loss) from Operations	(435,028)	153,969
Amortization and Depreciation Expense
Amortization and Depreciation Expense	21,672	17,507
Share-Based Compensation
Share-Based Compensation	47,453	36,003
Identifiable Assets
Identifiable Assets	176,447	1,018,673
Specialized BioTherapeutics [Member]
Revenues
Revenues	117,369	1,227,902
Income (Loss) from Operations
Income (Loss) from Operations	(13,610,715)	(6,738,284)
Amortization and Depreciation Expense
Amortization and Depreciation Expense	11,839	18,122
Other Income (Expense), Net
Other Income, Net	71,974	425,785
Share-Based Compensation
Share-Based Compensation	148,107	107,214
Identifiable Assets
Identifiable Assets	147,784	41,705
Corporate [Member]
Income (Loss) from Operations
Income (Loss) from Operations	(4,540,764)	(3,956,706)
Amortization and Depreciation Expense
Amortization and Depreciation Expense	28,861	18,821
Other Income (Expense), Net
Other Income, Net	(10,882)	148,968
Share-Based Compensation
Share-Based Compensation	214,373	233,122
Identifiable Assets
Identifiable Assets	$ 19,567,004	$ 6,714,983